Key result
Decreased plasmalogen concentration serves as an oxidative stress marker in patients with ACS or SVT.
Why the study?
Is decreased plasmalogen concentration a surrogate marker of oxidative stress in patients presenting with acute coronary syndromes or supraventricular tachycardias?
Is decreased plasmalogen concentration a surrogate marker of oxidative stress in patients presenting with acute coronary syndromes or supraventricular tachycardias?
Decreased plasmalogen concentration may serve as a surrogate marker of oxidative stress in patients with acute coronary syndromes or supraventricular tachycardias.
Should not yet change practice in ACS/SVT; hypothesis-generating for plasmalogen measurement as oxidative stress biomarker.
Article Decreased plasmalogen concentration as a surrogate marker of oxidative stress in patients presenting with acute coronary syndromes or supraventricular tachycardias was published on May 1, 2007 in the journal Clinical Chemistry and Laboratory Medicine (CCLM) (volume 45, issue 5).
No takes yet. Share an insight, caveat, or question.
Brosche et al. (2007) studied this question. Decreased plasmalogen concentration serves as a surrogate marker of oxidative stress in patients presenting with acute coronary syndromes or supraventricular tachycardias.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: